Fundz

Frontier Bio Corporation reported raising $380,000 in an initial SEC Form D filing, from an offering of $1 Million

PRIVATENov 10, 2026$380K of $1M raised

Amount Raised

$380,000

$380,000 sold, per SEC Form D (first sale Oct 27, 2026)

Round Type

Seed

Biotechnologyresearch

Quick answer

Frontier Bio raised $380,000 in a Seed round, dated October 27, 2026.

How much did Frontier Bio raise?
Frontier Bio raised $380,000 in a Seed round on October 27, 2026.
What does Frontier Bio do?
Frontier Bio leverages organ printing technology that directly supports whole-body replacement initiatives, providing the manufacturing infrastructure to produce replacement organs at scale.
Where is Frontier Bio based and how big is it?
Fundz records about 12 employees.
Who are the decision-makers at Frontier Bio?
Fundz holds 1 contact at Frontier Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as Frontier Bio that raised within 45 days of this round, from Fundz verified event records.

  • Axelyf raised $2.6M (Seed) on October 7, 2026.
  • MyoWorks raised an undisclosed amount on November 10, 2026.
  • Oyster Therapeutics raised $60M (Series A) on November 10, 2026.
  • Neobe raised $6.8M on November 10, 2026.
  • Efferon raised $4.8M (Seed) on November 10, 2026.
  • Nanopath raised $25M (Series B) on November 10, 2026.

Who to call at Frontier Bio, and when

A new round usually means Frontier Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Frontier Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Frontier Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Frontier Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Frontier Bio

About

Frontier Bio leverages organ printing technology that directly supports whole-body replacement initiatives, providing the manufacturing infrastructure to produce replacement organs at scale. Additionally, the bioprinting platform’s tissue engineering capabilities support artificial womb development, creating complex vascular networks and specialized tissues required for external gestation systems. 3D biofabrication technology works synergistically with other replacement technologies, creating a comprehensive ecosystem of mutually reinforcing longevity solutions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Frontier Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Frontier Bio's next move

See what Strategic adds

Frontier Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.